Immune Checkpoints in Circulating and Tumor-Infiltrating CD4+ T Cell Subsets in Colorectal Cancer Patients
Salman M. Toor(Hamad bin Khalifa University), Eyad Elkord(University of Sharjah)
Cited by 155
Related Papers
Immune checkpoint inhibitors: recent progress and potential biomarkers
|Experimental & Molecular Medicine|2018|2.1k
Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity
|Clinical and Developmental Immunology|2012|498
Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment
|Oncotarget|2017|124